141 related articles for article (PubMed ID: 2964757)
1. [Biological effects of leakadin].
Garin AM; Lichinitser MR; Dmitrieva NV; Rubtsov BI; Leneva NV
Vopr Onkol; 1988; 34(2):192-6. PubMed ID: 2964757
[TBL] [Abstract][Full Text] [Related]
2. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine].
Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA
Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of intravenous azimexon therapy in human cancer.
Patt YZ; Hersh EM; Reuben J; Claghorn L; Mavligit G
J Biol Response Mod; 1986 Aug; 5(4):313-8. PubMed ID: 2874196
[TBL] [Abstract][Full Text] [Related]
4. The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.
Malfiore C; Marmonti L; Filippeschi S; Labarre JF; Spreafico F
Anticancer Res; 1983; 3(6):425-9. PubMed ID: 6230986
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of BM 12,531 (Prop. INN azimexon).
Bicker U
Recent Results Cancer Res; 1980; 75():147-52. PubMed ID: 7232826
[TBL] [Abstract][Full Text] [Related]
6. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
[No Abstract] [Full Text] [Related]
7. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF
Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992
[No Abstract] [Full Text] [Related]
8. Phase II trial of diaziquone in advanced upper aerodigestive cancer.
Creagan ET; Long HJ; Kvols LK; Edmonson JH; O'Fallon JR
Cancer Treat Rep; 1985 Jan; 69(1):141. PubMed ID: 3967258
[No Abstract] [Full Text] [Related]
9. [Immunotherapy with leakadin in the combined therapy of acoustic neurinomas].
Khil'ko VA; Lantsov AA; Gorokhov AA; Starchenko AA; Komarets SA; Khlunovskiĭ AN
Vestn Otorinolaringol; 1994; (2):17-9. PubMed ID: 7855992
[TBL] [Abstract][Full Text] [Related]
10. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Griffin JP; Newman RA; McCormack JJ; Krakoff IH
Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
[TBL] [Abstract][Full Text] [Related]
11. Effect of the immunomodulant 2-cyanaziridine derivative BM 41.332 on adjuvant arthritis in the rat.
Bicker U
Arzneimittelforschung; 1982; 32(7):746-52. PubMed ID: 6889876
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of diaziquone in patients with colon cancer.
Neidhart JA; Erlichman C; Robert F; Velez-Garcia E; Bender JF; Grillo-López J
Cancer Treat Rep; 1985 Feb; 69(2):215-7. PubMed ID: 3882229
[TBL] [Abstract][Full Text] [Related]
13. Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Mathé G; Florentin I; Bruley-Rosset M; Goutner A; Serrou B
Recent Results Cancer Res; 1982; 80():331-3. PubMed ID: 6977171
[No Abstract] [Full Text] [Related]
14. Phase I study of diaziquone.
Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
[TBL] [Abstract][Full Text] [Related]
15. [A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)].
Pavelka K; Müller W
Cas Lek Cesk; 1981 May; 120(19):566-70. PubMed ID: 7237501
[No Abstract] [Full Text] [Related]
16. Phase I-II diaziquone chemotherapy in brain tumors.
Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
[No Abstract] [Full Text] [Related]
17. Phase I clinical evaluation of diaziquone in childhood cancer.
Ettinger LJ; Siegel SE; Belasco JB; Evans AE; Ruccione KS; Jamin DC; Rohrbaugh TM; Higgins GR
Cancer Treat Rep; 1985 Mar; 69(3):323-7. PubMed ID: 3856480
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Sutton GP; Homesley HD; Park R
Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196
[No Abstract] [Full Text] [Related]
19. [Leakadin immunotherapy in the combined therapy of acoustic neurinomas].
Starchenko AA; Khil'ko VA; Komarets SA; Khlunovskiĭ AN
Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(4):40-2. PubMed ID: 7856375
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
